Aurobindo facility receives Form 483 over procedural issues

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/ Ildo Frazao)
(Image: Getty/ Ildo Frazao)

Related tags: Form 483, Aurobindo, Manufacturing, India, Fda, Injectables

US FDA issues Form 483 to Aurobindo’s drug product manufacturing plant after it failed to follow sterile procedures.

The Form 483​ comes after the US Food and Drug Administration (FDA) conducted an inspection at the facility in Hyderabad, India, in December 2018. During the inspection, the agency noticed that procedures to prevent microbiological contamination of drug products were not followed.

Only two observations were made, but the FDA’s report spans twelve-pages – detailing improper set-up of lines for aseptic filling of drug products for the US drug market and the mishandling of primary packaging components.

The first observation stated that active-air sample results from the aseptic filling line could not be assured of presenting proper air quality throughout the filling. It also noted that procedures for air monitoring using the settling plates to monitor the filling area were not at working level.  

The second observation of the two is in regards to protective apparel that is to be worn to protect drug products from contamination. Operators provided no assurance that the required apparel is worn in the aseptic production areas, which could lead to possible contamination.

In March 2018, the same injectables facility received nine observations​ from the FDA, including signs of rodents and insects.

Another Aurobindo facility was issued a Form 483 regarding procedural issues in September 2017. The antibiotics manufacturing facility​ in Andhra Pradesh, India, received a Form 483 after the FDA observed a lack of written produces to assure strength, quality, purity, and drug identity.

Related news

Show more

Related products

show more

The battle of performance in pharma production

The battle of performance in pharma production

Telstar Life Science Solutions | 26-Mar-2019 | Case Study

Telstar case study. Discover how a versatile freeze-dryer automatic loading & unloading systemDiscover how a versatile freeze-dryer automatic loading...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers

Follow us

Products

View more